Oral Administration of p-Hydroxycinnamic Acid Attenuates Atopic Dermatitis by Downregulating Th1 and Th2 Cytokine Production and Keratinocyte Activation.

MLA

Hyun-Su Lee, et al. “Oral Administration of P-Hydroxycinnamic Acid Attenuates Atopic Dermatitis by Downregulating Th1 and Th2 Cytokine Production and Keratinocyte Activation.” PLoS ONE, vol. 11, no. 3, Jan. 2016, p. e0150952. EBSCOhost, https://doi.org/10.1371/journal.pone.0150952.

APA

Hyun-Su Lee, Eun-Ju Choi, Kyung-Sik Lee, Hye-Ran Kim, Bo-Ra Na, Min-Sung Kwon, Gil-Saeng Jeong, Hyun Gyu Choi, Eun Young Choi, & Chang-Duk Jun. (2016). Oral Administration of p-Hydroxycinnamic Acid Attenuates Atopic Dermatitis by Downregulating Th1 and Th2 Cytokine Production and Keratinocyte Activation. PLoS ONE, 11(3), e0150952. https://doi.org/10.1371/journal.pone.0150952

Chicago

Hyun-Su Lee, Eun-Ju Choi, Kyung-Sik Lee, Hye-Ran Kim, Bo-Ra Na, Min-Sung Kwon, Gil-Saeng Jeong, Hyun Gyu Choi, Eun Young Choi, and Chang-Duk Jun. 2016. “Oral Administration of P-Hydroxycinnamic Acid Attenuates Atopic Dermatitis by Downregulating Th1 and Th2 Cytokine Production and Keratinocyte Activation.” PLoS ONE 11 (3): e0150952. doi:10.1371/journal.pone.0150952.